Eloxx Pharmaceuticals Completes Acquisition Transaction with Sevion Therapeutics

WALTHAM, Mass., REHOVOT, Israel, and SAN DIEGO, Dec. 22 (Korea Bizwire) — Eloxx Pharmaceuticals Ltd. (“Eloxx”) and Sevion Therapeutics, Inc. (OTCQB:SVON) (“Sevion”) today announced the two companies have completed their previously announced acquisition transaction effective as of December 19, 2017.  The Company will be known as Eloxx Pharmaceuticals, Inc. following the completion of the transaction, and began trading [...]